01874nas a2200337   4500008004100000022001400041245012900055210006900184260001100253300001100264490000700275520074300282653002601025653002001051653003101071653004201102653001501144100001701159700001901176700001901195700002101214700002001235700001701255700002701272700002001299700002401319700001801343700001701361700002701378856013101405       2021                        eng d  a2234-943X00aPlasma-derived extracellular vesicles reveal galectin-3 binding protein as potential biomarker for early detection of glioma0 aPlasmaderived extracellular vesicles reveal galectin3 binding pr  cNOV 26  a7787540 v113 a{Gliomas are the most common type of the malignant brain tumor, which arise from glial cells. They make up about 40% of all primary brain tumors and around 70% of all primary malignant brain tumors. They can occur anywhere in the central nervous system (CNS) and have a poor prognosis. The average survival of glioma patients is approximately 6-15 months with poor aspects of life. In this edge, identification of proteins secreted by cancer cells is of special interest because it may provide a better understanding of tumor progression and provide early diagnosis of the diseases. Extracellular vesicles (EVs) were isolated from pooled plasma of healthy controls (n=03) and patients with different grades of glioma (Grade I or II or III10ablood-based biomarker10aearly detection10agalectin-3 binding protein10aplasma-derived extracellular vesicles10aproteomics1 aRana, Rashmi1 aChauhan, Kirti1 aGautam, Poonam1 aKulkarni, Mahesh1 aBanarjee, Reema1 aChugh, Parul1 aChhabra, Satnam, Singh1 aAcharya, Rajesh1 aKalra, Samir, Kumar1 aGupta, Anshul1 aJain, Sunila1 aGanguly, Nirmal, Kumar  uhttps://library.ncl.res.in/content/plasma-derived-extracellular-vesicles-reveal-galectin-3-binding-protein-potential-biomarker